COYA vs NVS
Coya Therapeutics, Inc. Common Stock (COYA) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
NVS (NVS) common stock.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
NVS does not have a complete income-statement cache yet.
COYA currently screens at market cap $118.0M. NVS currently screens at market cap $0.
Not investment advice. Open the COYA and NVS stock pages for the full models.
Not investment advice.